iBio, Inc. Share Price
NASDAQ: IBIO | Micro CapiBio, Inc. Stock Performance
iBio, Inc. Share Price Today
As of 30 October 2026, iBio, Inc.'s share price is $0.81. The stock opened at $0.81, compared to its previous close of $0.79. During today's trading session, iBio, Inc.'s share price traded between $0.78 and $0.82, with an average price of $0.80. Over the past 52 weeks, the stock has recorded a high of $3.76 and a low of $0.69. In terms of performance, iBio, Inc.'s share price has declined by 52.21% over the last six months and is down 49.07% on a year-on-year basis.
iBio, Inc. Share Price Chart
iBio, Inc. Quarterly Profit & Loss
All figures in USD
iBio, Inc. Annual Profit & Loss
All figures in USD
About iBio, Inc.
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
iBio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.18 | $0.79 | -32.97% |
Sep 2026 | $1.26 | $1.18 | -16.01% |
Aug 2026 | $1.42 | $1.41 | -0.35% |
Jul 2026 | $1.77 | $1.41 | -19.20% |
Jun 2026 | $1.91 | $1.75 | -8.40% |
May 2026 | $1.62 | $1.91 | +12.06% |
Apr 2026 | $1.96 | $1.70 | -10.99% |
Mar 2026 | $2.56 | $1.91 | -32.63% |
Feb 2026 | $2.06 | $2.83 | +34.04% |
Jan 2026 | $1.93 | $2.12 | +8.46% |
Dec 2025 | $1.19 | $1.95 | +59.18% |
Nov 2025 | $1.65 | $1.23 | -23.20% |